Physician

Sultana Razia, M.D.

According to 2025 Medicare claims, Sultana Razia, M.D. (NPI: 1669466884) practices hematology/oncology in the Utica-Rome, NY market, with the plurality of this provider's patient population coming from Oneida, NY. This provider's primary affiliated billing organization is SLOCUM DICKSON MEDICAL GROUP PLLC (NPI: 1285625996; TIN: 200362623) and primary practice location at 13413-1001. Razia is affiliated with the Trinity Health Integrated Care (ACO ID: A3454), Main Street Rural Health Willow ACO LLC (ACO ID: A5404), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Razia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 682 traditional Medicare patients, billed 318,769 HCPCS/CPT codes, and received $3,522,114 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,534 prescription claims across 225 beneficiaries totaling $6,506,943 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 11 claims. Open Payments data shows 4 records totaling $94. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $3,709,801 to $6,506,943. In contrast, DME billing represents a smaller volume and declined steadily, from $10,360 to $774.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	806	354,759	$3,957,442
2016	892	437,398	$4,398,966
2017	817	488,052	$4,928,157
2018	936	511,716	$5,160,632
2019	779	343,198	$3,132,173
2020	699	186,552	$1,612,909
2021	610	238,910	$1,838,087
2022	693	339,478	$3,049,600
2023	707	374,949	$3,755,465
2024	682	318,769	$3,522,114

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	291	2,289	$3,709,801
2016	302	2,034	$4,226,862
2017	285	1,805	$3,963,135
2018	291	1,753	$3,816,541
2019	255	1,403	$3,674,412
2020	195	1,044	$3,410,041
2021	199	1,068	$3,365,969
2022	209	1,360	$6,084,851
2023	225	1,413	$6,483,149
2024	225	1,534	$6,506,943

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	21	225	$11,090
2016	18	149	$3,064
2017	12	193	$7,273
2018	18	200	$3,822
2019	16	195	$2,383
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	13	$3,113
2023	N/R	22	$3,833
2024	N/R	11	$2,402

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	557	2,300	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	199	286	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	331	536	$12
96372	Injection of drug or substance under skin or into muscle	266	2,305	$10
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	202	1,064	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	98	2,766	$1,564,678
Jakafi	Ruxolitinib Phosphate	66	1,980	$1,074,916
Pomalyst	Pomalidomide	47	1,316	$1,021,900
Lenalidomide	Lenalidomide	48	1,344	$676,475
Verzenio	Abemaciclib	25	700	$377,045

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4150	Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$2,402

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$94	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sultana Razia, M.D.?

Tedicare shows public-source Medicare data for Sultana Razia, M.D. (NPI 1669466884), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sultana Razia, M.D. have ACO affiliation data?

Sultana Razia, M.D. is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454), Main Street Rural Health Willow ACO LLC (MSSP, ACO ID A5404), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Sultana Razia, M.D.?

Sultana Razia, M.D. is linked to SLOCUM DICKSON MEDICAL GROUP PLLC (billing NPI 1285625996) in the available physician profile data.

Does Sultana Razia, M.D. have Open Payments data?

Sultana Razia, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.